The bile acid receptors, farnesoid X receptor (FXR)] [33] and a G-protein-coupled receptor (TGR5) [34], have elicited considerable interest as targets in metabolic diseases [35], and there is now extensive support for microbiota-dependent modulation of these receptors via modification of bile acids [31]. The gene discussed is NR1H4; the disease is metabolic disease.